Core First Bank & Trust Bristol Myers Squibb CO Transaction History
Core First Bank & Trust
- $148 Million
- Q2 2024
A detailed history of Core First Bank & Trust transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Core First Bank & Trust holds 11,940 shares of BMY stock, worth $676,759. This represents 0.34% of its overall portfolio holdings.
Number of Shares
11,940
Previous 12,380
3.55%
Holding current value
$676,759
Previous $671,000
26.23%
% of portfolio
0.34%
Previous 0.42%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,535Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.7 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.99 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.27 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.42 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.46 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $121B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...